5 (83) · $ 10.50 · In stock
Researchers at the Sanford Burnham Prebys Medical Discovery Institute (SBP) reported new findings this week that may lead to novel therapeutic strategies for people suffering from Duchenne muscular dystrophy (DMD). DMD, a muscle-wasting disease that affects 1 in 7250 males aged 5 to 24 years in the United States, is caused by a genetic mutation leading…
Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy
Frontiers Development of Therapeutic RNA Manipulation for Muscular Dystrophy
Dystrophin The Stem Cellar
Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy
Muscular Dystrophy Treatment in India
The present and future of regenerative medicine
Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies
Bold New Therapy Delivery Method Shows Initial Promise as Treatment for Duchenne Muscular Dystrophy - Research Horizons
Sanford Burnham Prebys Medical Discovery Institute
Progression of DMD and its complications. Duchenne muscular
Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future
Piezo1 Possible Key to Supporting Muscle Regeneration in Duchenne Muscular Dystrophy - Penn Medicine
muscle stem cells, The Stem Cellar
Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies
Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy